<html xmlns:v="urn:schemas-microsoft-com:vml"xmlns:o="urn:schemas-microsoft-com:office:office"xmlns:w="urn:schemas-microsoft-com:office:word"xmlns="http://www.w3.org/TR/REC-html40"><head><meta name=Title content="OMLAB Report #022005"><meta name=Keywords content=""><meta http-equiv=Content-Type content="text/html; charset=macintosh"><meta name=ProgId content=Word.Document><meta name=Generator content="Microsoft Word 11"><meta name=Originator content="Microsoft Word 11"><link rel=File-List href="INS_EOM_Surg_VAvsGangle_files/filelist.xml"><link rel=Edit-Time-Data href="INS_EOM_Surg_VAvsGangle_files/editdata.mso"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}o\:* {behavior:url(#default#VML);}w\:* {behavior:url(#default#VML);}.shape {behavior:url(#default#VML);}</style><![endif]--><title>OMLAB Report #022005</title><!--[if gte mso 9]><xml> <o:DocumentProperties>  <o:Subject>Nystagmus Therapies</o:Subject>  <o:Author>L. F. Dell'Osso, Ph.D.</o:Author>  <o:Template>Papers</o:Template>  <o:LastAuthor>OMLAB VAMC</o:LastAuthor>  <o:Revision>2</o:Revision>  <o:LastPrinted>2009-03-05T01:36:00Z</o:LastPrinted>  <o:Created>2011-05-04T17:42:00Z</o:Created>  <o:LastSaved>2011-05-04T17:42:00Z</o:LastSaved>  <o:Pages>2</o:Pages>  <o:Words>2656</o:Words>  <o:Characters>15144</o:Characters>  <o:Company>OMLAB</o:Company>  <o:Lines>126</o:Lines>  <o:Paragraphs>30</o:Paragraphs>  <o:CharactersWithSpaces>18597</o:CharactersWithSpaces>  <o:Version>11.1280</o:Version> </o:DocumentProperties> <o:OfficeDocumentSettings>  <o:AllowPNG/>  <o:PixelsPerInch>300</o:PixelsPerInch> </o:OfficeDocumentSettings></xml><![endif]--><!--[if gte mso 9]><xml> <w:WordDocument>  <w:Zoom>150</w:Zoom>  <w:ActiveWritingStyle Lang="EN-US" VendorID="8" DLLVersion="513" NLCheck="0">1</w:ActiveWritingStyle>  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEvery>  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>  <w:UseMarginsForDrawingGridOrigin/>  <w:DocumentVariables>   <w:EN.InstantFormat>&lt;ENInstantFormat&gt;&lt;Enabled&gt;0&lt;/Enabled&gt;&lt;ScanUnformatted&gt;1&lt;/ScanUnformatted&gt;&lt;ScanChanges&gt;1&lt;/ScanChanges&gt;&lt;/ENInstantFormat&gt;</w:EN.InstantFormat>   <w:EN.Layout>&lt;ENLayout&gt;&lt;Style&gt;R_OMLAB&lt;/Style&gt;&lt;LeftDelim&gt;{&lt;/LeftDelim&gt;&lt;RightDelim&gt;}&lt;/RightDelim&gt;&lt;FontName&gt;Times&lt;/FontName&gt;&lt;FontSize&gt;12&lt;/FontSize&gt;&lt;ReflistTitle&gt;&lt;/ReflistTitle&gt;&lt;StartingRefnum&gt;1&lt;/StartingRefnum&gt;&lt;FirstLineIndent&gt;0&lt;/FirstLineIndent&gt;&lt;HangingIndent&gt;720&lt;/HangingIndent&gt;&lt;LineSpacing&gt;0&lt;/LineSpacing&gt;&lt;SpaceAfter&gt;0&lt;/SpaceAfter&gt;&lt;/ENLayout&gt;</w:EN.Layout>   <w:EN.Libraries>&lt;ENLibraries&gt;&lt;Libraries&gt;&lt;item&gt;VA_Gangle.enl&lt;/item&gt;&lt;/Libraries&gt;&lt;/ENLibraries&gt;</w:EN.Libraries>   <w:EN_Lib_Name_List_Name>09OMref.enl</w:EN_Lib_Name_List_Name>  </w:DocumentVariables> </w:WordDocument></xml><![endif]--><style><!-- /* Font Definitions */@font-face	{font-family:"Times New Roman";	panose-1:0 2 2 6 3 5 4 5 2 3;	mso-font-charset:0;	mso-generic-font-family:auto;	mso-font-pitch:variable;	mso-font-signature:50331648 0 0 0 1 0;}@font-face	{font-family:Geneva;	panose-1:0 2 11 5 3 3 4 4 4 2;	mso-font-charset:0;	mso-generic-font-family:auto;	mso-font-pitch:variable;	mso-font-signature:50331648 0 0 0 1 0;} /* Style Definitions */p.MsoNormal, li.MsoNormal, div.MsoNormal	{mso-style-parent:"";	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	font-size:12.0pt;	font-family:Times;}h1	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:1;	font-size:14.0pt;	font-family:Times;	mso-font-kerning:0pt;	font-weight:normal;	font-style:italic;}h2	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:2;	font-size:12.0pt;	font-family:Times;	font-weight:normal;	font-style:italic;}h3	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:3;	font-size:14.0pt;	font-family:Times;	font-style:italic;}h4	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	text-align:center;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:4;	font-size:12.0pt;	font-family:Times;}h5	{mso-style-next:Normal;	margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	text-align:justify;	line-height:150%;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:5;	font-size:14.0pt;	font-family:Times;	font-style:italic;}h6	{mso-style-next:Normal;	margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	text-align:justify;	line-height:150%;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:6;	font-size:12.0pt;	font-family:Times;	font-style:italic;}p.MsoHeader, li.MsoHeader, div.MsoHeader	{margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	tab-stops:center 3.0in right 6.0in;	font-size:12.0pt;	font-family:Times;}p.MsoFooter, li.MsoFooter, div.MsoFooter	{margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	tab-stops:center 3.0in right 6.0in;	font-size:12.0pt;	font-family:Times;}p.MsoBodyText, li.MsoBodyText, div.MsoBodyText	{margin:0in;	margin-bottom:.0001pt;	text-align:center;	mso-pagination:widow-orphan;	font-size:22.0pt;	font-family:Times;}p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent	{margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	line-height:150%;	mso-pagination:widow-orphan;	font-size:12.0pt;	font-family:Times;}p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2	{margin:0in;	margin-bottom:.0001pt;	line-height:150%;	mso-pagination:widow-orphan;	font-size:10.0pt;	font-family:Times;}p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3	{margin:0in;	margin-bottom:.0001pt;	text-align:justify;	mso-pagination:widow-orphan;	mso-outline-level:1;	font-size:12.0pt;	font-family:Times;}p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2	{margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	text-align:justify;	line-height:150%;	mso-pagination:widow-orphan;	font-size:12.0pt;	font-family:Times;}a:link, span.MsoHyperlink	{color:blue;	text-decoration:underline;	text-underline:single;}a:visited, span.MsoHyperlinkFollowed	{color:purple;	text-decoration:underline;	text-underline:single;}p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap	{margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	background:navy;	font-size:12.0pt;	font-family:Geneva;}table.MsoNormalTable	{mso-style-parent:"";	font-size:10.0pt;	font-family:Times;}@page Section1	{size:8.5in 11.0in;	margin:1.0in 1.0in 1.0in 1.0in;	mso-header-margin:.5in;	mso-footer-margin:.55in;	mso-page-numbers:1;	mso-title-page:yes;	mso-header:url(":INS_EOM_Surg_VAvsGangle_files:header.htm") h1;	mso-footer:url(":INS_EOM_Surg_VAvsGangle_files:header.htm") f1;	mso-first-footer:url(":INS_EOM_Surg_VAvsGangle_files:header.htm") ff1;	mso-paper-source:0;}div.Section1	{page:Section1;}--></style><!--[if gte mso 9]><xml> <o:shapedefaults v:ext="edit" spidmax="2050"/></xml><![endif]--><!--[if gte mso 9]><xml> <o:shapelayout v:ext="edit">  <o:idmap v:ext="edit" data="1"/> </o:shapelayout></xml><![endif]--></head><body bgcolor=white lang=EN-US link=blue vlink=purple style='tab-interval:.5in'><div class=Section1><p class=MsoBodyText><span style='font-size:16.0pt;font-family:"Times New Roman"'><b>HowSomeone with INS “Sees” the World and How to Clinically Assess TherapeuticImprovements in Visual Function<o:p></o:p></b></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoBodyText><span style='font-size:14.0pt;font-family:"Times New Roman"'>L.F.Dell’Osso, Ph.D.<o:p></o:p></span></p><p class=MsoNormal align=center style='text-align:center;mso-outline-level:1'><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Times New Roman"'>Fromthe Daroff-Dell’Osso Ocular Motility Laboratory, Louis Stokes Cleveland DVAMedical Center and Depts. of Neurology and Biomedical Engineering, Case WesternReserve University, Cleveland OH, USA<o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoBodyText align=left style='text-align:left'><span style='font-size:12.0pt;font-family:"Times New Roman"'><b>OMLAB Report #030509<o:p></o:p></b></span></p><p class=MsoBodyText align=left style='text-align:left'><span style='font-size:12.0pt;font-family:"Times New Roman"'><b>Written:</b></span><spanstyle='font-size:12.0pt;font-family:"Times New Roman"'> 3/5/09; <b>Placed onWeb Page:</b></span><span style='font-size:12.0pt;font-family:"Times New Roman"'>3/5/09; <b>Last Modified:</b></span><span style='font-size:12.0pt;font-family:"Times New Roman"'> 7/22/10<o:p></o:p></span></p><p class=MsoBodyText align=left style='text-align:left'><span style='font-size:12.0pt;font-family:"Times New Roman"'><b>Downloaded from:</b></span><spanstyle='font-size:12.0pt;font-family:"Times New Roman"'> OMLAB.ORG<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><b>Sendquestions, comments, and suggestions to:</b></span><span style='font-family:"Times New Roman"'> lfd@case.edu<o:p></o:p></span></p><p class=MsoBodyText3><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoBodyText3><span style='font-size:10.0pt;font-family:"Times New Roman"'>Thiswork was supported in part by the Office of Research and Development, MedicalResearch Service, Department of Veterans Affairs.<o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='text-align:justify;mso-outline-level:1'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>Presented in part at the2006 ARVO and 2009 Asia-ARVO and NANOS meetings.<o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>Early researchinto infantile nystagmus syndrome (INS, aka congenital nystagmus) </span><!--[if supportFields]><spanstyle='font-family:"Times New Roman"'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;CEMAS_Working_Group&lt;/Author&gt;&lt;Year&gt;2001&lt;/Year&gt;&lt;RecNum&gt;1&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;1&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot;db-id=&quot;2ttz9wvsqr5v5detxd1v2fei9evtxfa5tsf2&quot;&gt;1&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;Report&quot;&gt;27&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;CEMAS_Working_Group&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;ANational Eye Institute Sponsored Workshop and Publication on The Classificationof Eye Movement Abnormalities and Strabismus (CEMAS). In The National EyeInstitute Publications(www.nei.nih.gov)&lt;/title&gt;&lt;/titles&gt;&lt;keywords&gt;&lt;keyword&gt;NYST:STRAB:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2001&lt;/year&gt;&lt;/dates&gt;&lt;pub-location&gt;Bethesda,MD&lt;/pub-location&gt;&lt;publisher&gt;National Institutes of Health, NationalEyeInstitute&lt;/publisher&gt;&lt;label&gt;5.89&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-family:"Times New Roman"'>(1)</span><!--[if supportFields]><spanstyle='font-family:"Times New Roman"'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-family:"Times New Roman"'> made it clear that assessment of visualfunction in such patients required more than merely taking a visual acuitymeasurement in primary position, or even in the “null” position </span><!--[if supportFields]><spanstyle='font-family:"Times New Roman"'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE <span style='mso-element:field-begin'></span><span style="mso-spacerun: yes">&nbsp;</span>ADDINEN.CITE.DATA <![if gte mso 9]><xml> <w:data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w:data></xml><![endif]><span style='mso-element:field-end'></span><spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-family:"Times New Roman"'>(2-5)<!--[if gte mso 9]><xml> <w:data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w:data></xml><![endif]--></span><!--[if supportFields]><span style='font-family:"Times New Roman"'><spanstyle='mso-element:field-end'></span></span><![endif]--><span style='font-family:"Times New Roman"'>. As far back as 1974, Dr. J. Lawton Smith recognized theimplications of this research and the changes that should be made by theophthalmologist in the office. In one of his classic tapes he remarked, “Youought to measure their vision, let’s say, straight ahead, to the left, and tothe right” </span><!--[if supportFields]><span style='font-family:"Times New Roman"'><spanstyle='mso-element:field-begin'></span><span style="mso-spacerun:yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Smith&lt;/Author&gt;&lt;Year&gt;1974&lt;/Year&gt;&lt;RecNum&gt;6&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;6&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot;db-id=&quot;2ttz9wvsqr5v5detxd1v2fei9evtxfa5tsf2&quot;&gt;6&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;AudiovisualMaterial&quot;&gt;3&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Smith,J. L.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;/authors&gt;&lt;secondary-authors&gt;&lt;author&gt;Smith,J.L.&lt;/author&gt;&lt;/secondary-authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Congenitalnystagmus therapy&lt;/title&gt;&lt;secondary-title&gt;Cassette Tapes ofClinical Neuro-Ophthalmology&lt;/secondary-title&gt;&lt;/titles&gt;&lt;number&gt;23&lt;/number&gt;&lt;keywords&gt;&lt;keyword&gt;CN:NYST: WFM: VACTY:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;1974&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.499&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;remote-database-name&gt;NOVEL:The Collection of J. Lawton Smith, M.D.&lt;/remote-database-name&gt;&lt;remote-database-provider&gt;NorthAmerican Neuro-Ophthalmollgy Society&lt;/remote-database-provider&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-family:"Times New Roman"'>(6)</span><!--[if supportFields]><spanstyle='font-family:"Times New Roman"'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-family:"Times New Roman"'>. Others have also come to the sameconclusion </span><!--[if supportFields]><span style='font-family:"Times New Roman"'><spanstyle='mso-element:field-begin'></span><span style="mso-spacerun:yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Yang&lt;/Author&gt;&lt;Year&gt;2005&lt;/Year&gt;&lt;RecNum&gt;9&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;9&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot; db-id=&quot;2ttz9wvsqr5v5detxd1v2fei9evtxfa5tsf2&quot;&gt;9&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Yang,D.&lt;/author&gt;&lt;author&gt;Hertle, R. W.&lt;/author&gt;&lt;author&gt;Hill,V. M.&lt;/author&gt;&lt;author&gt;Stevens, D.J.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Departmentof Ophthalmology, Children&amp;apos;s Hospital of Pittsburgh; The Eye and EarInstitute, The University of Pittsburgh Medical Center, Pittsburgh,Pennsylvania.&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Gaze-dependent andtime-restricted visual acuity measures in patients with Infantile NystagmusSyndrome (INS)&lt;/title&gt;&lt;secondary-title&gt;Am JOphthalmol&lt;/secondary-title&gt;&lt;/titles&gt;&lt;periodical&gt;&lt;full-title&gt;AmJ Ophthalmol&lt;/full-title&gt;&lt;/periodical&gt;&lt;pages&gt;716-718&lt;/pages&gt;&lt;volume&gt;139&lt;/volume&gt;&lt;number&gt;4&lt;/number&gt;&lt;keywords&gt;&lt;keyword&gt;CN:VACTY:GANGLE:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2005&lt;/year&gt;&lt;pub-dates&gt;&lt;date&gt;Apr&lt;/date&gt;&lt;/pub-dates&gt;&lt;/dates&gt;&lt;accession-num&gt;15808174&lt;/accession-num&gt;&lt;label&gt;5.197&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=15808174&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-family:"Times New Roman"'>(7)</span><!--[if supportFields]><spanstyle='font-family:"Times New Roman"'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-family:"Times New Roman"'>. There is no doubt that for accurate,repeatable diagnoses of childhood nystagmus, for determination of the most effectivetherapeutic approach, and to objectively assess therapeutic efficacy,eye-movement recordings are necessary; that has been evident since the firstocular motor study of INS surgery</span> <!--[if supportFields]><spanstyle='mso-element:field-begin'></span><span style="mso-spacerun:yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;1979&lt;/Year&gt;&lt;RecNum&gt;8&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;8&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot;db-id=&quot;2ttz9wvsqr5v5detxd1v2fei9evtxfa5tsf2&quot;&gt;8&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L. F.&lt;/author&gt;&lt;author&gt;Flynn, J.T.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Congenitalnystagmus surgery: a quantitative evaluation of theeffects&lt;/title&gt;&lt;secondary-title&gt;Arch Ophthalmol&lt;/secondary-title&gt;&lt;/titles&gt;&lt;periodical&gt;&lt;full-title&gt;ArchOphthalmol&lt;/full-title&gt;&lt;/periodical&gt;&lt;pages&gt;462-469&lt;/pages&gt;&lt;volume&gt;97&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:VACTY: CMN:SURG:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;1979&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;1.28&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span><![endif]-->(8)<!--[if supportFields]><spanstyle='mso-element:field-end'></span><![endif]--><span style='font-family:"Times New Roman"'>.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>The singlefactor most responsible for the lack of progress in the medical care ofnystagmus patients over the past 30 years is the failure of theophthalmological community to encourage the establishment of at least oneocular motor laboratory in each major city despite overwhelming evidencesupporting their necessity for the highest standard of medical practice. It isalso in many ways responsible for the widespread misunderstanding of INS andthe near absence of adequate teaching of the subject in ophthalmologicresidency programs. There is simply no excuse for a patient or parent in the 21<sup>st</sup>century to hear from their physician (as they still do), “You have nystagmus,there is nothing to be done,” or even worse, “Your child has nystagmus, he maybe blind.” Such misstatements and dire predictions were common in the 1940’s(personal knowledge); in light of what we now know, they reflect ignorance ofthe condition and are unconscionable. In an attempt to overcome the excessiveinertia in the ophthalmological community, the following clinical assessmentmethods are presented below. Although not a substitute for accurateeye-movement data, they should at least help the INS patient obtain moreeffective therapy. <o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>First, it isimportant for the physician to appreciate exactly how INS affects visualfunction. Shown below are photos representing what an INS patient sees as hedirects his gaze to the left and right of the region of highest visual acuity(i.e., the region of peak NAFX). Note that these photos do <i>not</i></span><spanstyle='font-family:"Times New Roman"'> represent visual fields; the acuitysimulated is for each gaze angle when the patient looks at a particular personin the photo while keeping his head still in primary position. Thus, theyrepresent <i>foveal vision</i></span><span style='font-family:"Times New Roman"'>at each gaze angle.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f"> <v:stroke joinstyle="miter"/> <v:formulas>  <v:f eqn="if lineDrawn pixelLineWidth 0"/>  <v:f eqn="sum @0 1 0"/>  <v:f eqn="sum 0 0 @1"/>  <v:f eqn="prod @2 1 2"/>  <v:f eqn="prod @3 21600 pixelWidth"/>  <v:f eqn="prod @3 21600 pixelHeight"/>  <v:f eqn="sum @0 0 1"/>  <v:f eqn="prod @6 1 2"/>  <v:f eqn="prod @7 21600 pixelWidth"/>  <v:f eqn="sum @8 21600 0"/>  <v:f eqn="prod @7 21600 pixelHeight"/>  <v:f eqn="sum @10 21600 0"/> </v:formulas> <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/> <o:lock v:ext="edit" aspectratio="t"/></v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:6in; height:4in'> <v:imagedata src="INS_EOM_Surg_VAvsGangle_files/image001.jpg" o:title="INS_MoreBetter"/></v:shape><![endif]--><![if !vml]><img width=432 height=288src="INS_EOM_Surg_VAvsGangle_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]><spanstyle='font-family:"Times New Roman"'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Times New Roman"'>Figure1. Photos simulating pre- and post-T&amp;R foveal vision at different gazeangles and pre- and post-T&amp;R plots of the NAFX function vs. gaze angle foran INS patient with poor primary position visual acuity.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><spanstyle="mso-spacerun: yes">&nbsp;</span><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>Figure 1simulates both what an INS patient with low primary-position acuity sees andshows the corresponding NAFX vs. gaze angle curves. The pre-tenotomy andreattachment surgery (T&amp;R) photo shows the limited range of gaze angles forwhich acuity is maximal, albeit poor (i.e., the patient must look through thisnarrow ‘window’ of best acuity by constantly redirecting his head to point ateach new target/person. The post-T&amp;R photo shows both a <i>broadening</i></span><spanstyle='font-family:"Times New Roman"'> of the range of gaze angles withapproximately peak acuity (broader NAFX curve peak)&#8212;he sees‘more’&#8212;and an <i>improvement</i></span><span style='font-family:"Times New Roman"'>in the peak visual acuity region (peak NAFX)&#8212;he sees ‘better.’ Now, thepatient has a much broader ‘window’ of high acuity and can rapidly makesaccades to each target/person without repositioning his head.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_i1026" type="#_x0000_t75" style='width:6in;height:4in'> <v:imagedata src="INS_EOM_Surg_VAvsGangle_files/image003.jpg" o:title="INS_More"/></v:shape><![endif]--><![if !vml]><img width=432 height=288src="INS_EOM_Surg_VAvsGangle_files/image004.jpg" v:shapes="_x0000_i1026"><![endif]><spanstyle='font-family:"Times New Roman"'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Times New Roman"'>Figure2. Photos simulating pre- and post-T&amp;R foveal vision at different gaze anglesand pre- and post-T&amp;R plots of the NAFX function vs. gaze angle for an INSpatient with good primary position visual acuity.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>Figure 2simulates both what an INS patient with high primary-position acuity sees andshows the corresponding NAFX vs. gaze angle curves. The pre-T&amp;R photo showsthe limited range of gaze angles for which acuity is high (i.e., the patientmust look through this narrow ‘window’ of high acuity by constantly redirectinghis head to point at each new target/person. The post-T&amp;R photo still showsa <i>broadening</i></span><span style='font-family:"Times New Roman"'> of therange of gaze angles with approximately peak acuity (broader NAFX curvepeak)&#8212;he sees ‘more’&#8212;but shows <i>no improvement</i></span><spanstyle='font-family:"Times New Roman"'> in the previously high peak visualacuity region (peak NAFX) Again, the patient has a much broader ‘window’ ofhigh acuity and can rapidly make saccades to each target/person withoutrepositioning his head.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>In the office,all nystagmus patients should have their visual acuity recorded at lateral gazeangles in addition to primary position. That will provide baseline curves ofvisual acuity vs. gaze angle that will mimic the NAFX curves shown since theNAFX is linearly proportional to decimal visual acuity. Recording onlyprimary-position visual acuity does not provide any measure of the broadeningeffects of EOM surgery and will mislead the physician, in cases like that shownin Figure 2, into the false conclusion that the surgery did not improve thepatient’s visual <i>function</i></span><span style='font-family:"Times New Roman"'>.The patient will report that he sees ‘better’ (he actually sees ‘more’) but thephysician will not have the necessary data to understand why and mayincorrectly conclude that the surgery did not help the patient.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>How can a visualacuity curve be generated in the office? Simply have markers placed on thefloor at gaze angles of 10°, 20°, and 30° to each side of primary position(also marked as 0°). Then, with the patient’s head restrained to thestraight-ahead position, take acuity measurements after rotating the chair toeach gaze angle. For binocular patients, binocular acuities are sufficient. Forthose with strabismus, the procedure must be repeated twice, once for each eyewhile the fellow eye is occluded. In this latter case, the curves will notmatch each other since the fixating eye influences the position of peak acuity(aka the ‘null’ position) in INS. If the patient has fusion maldevelopmentnystagmus syndrome (FMNS, aka latent/manifest latent nystagmus), higheracuities will be in <i>adduction</i></span><span style='font-family:"Times New Roman"'>of the fixating eye due to Alexander’s law variation of the FMN. Comparingthese pre-surgical curves to those taken post-surgery will provide datademonstrating two of the factors shown to improve with EOMsurgery&#8212;broadening and raising the visual acuity peak. Post-surgicalimprovements in target acquisition time are more difficult to measure in aclinical setting.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>If the INSpatient has an eccentric “null,” the Figures would be the same except that theposition of the maximal-acuity regions (peak NAFX values) would appear at theeccentric position. Any <i>four-muscle</i></span><span style='font-family:"Times New Roman"'>surgery to rotate that peak to primary position should have the same effects asthose shown in the Figures. That is, a Kestenbaum resect and recess procedureor an Anderson plus T&amp;R (i.e., two agonist muscles recessed and the twoantagonist muscles undergoing a T&amp;R) procedure. To date, there is noeye-movement evidence that an Anderson procedure alone (two recessions only)will have either the same or any broadening of the NAFX peak. In INS caseswhere the patient is binocular and the INS damps with convergence, the bestapproach is the bimedial recession surgery which will have the same effects asthe above Figures show; convergence improvements are usually greater thangaze-angle improvements in patients with both eccentric peaks and vergencepeaks in their NAFX.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='tab-stops:center 3.0in'><span style='font-family:"Times New Roman"'>To assess visual function improvement post-surgery:<o:p></o:p></span></p><p class=MsoNormal style='tab-stops:center 3.0in'><span style='font-family:"Times New Roman"'>1) determine the percent increase in the longest foveationdomain (LFD), given by<o:p></o:p></span></p><p class=MsoNormal align=center style='text-align:center'><spanstyle='font-family:"Times New Roman"'>%Improvement = 100[LFDpost &#8211;LFDpre]/LFDpre<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>where LFD = therange of gaze angles where the NAFX is ≥0.9[NAFXpeak] (i.e., the range of gazeangles for which the NAFX is within 10% of the peak value;<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>2) determine thepercentage improvement in visual acuity, given by<o:p></o:p></span></p><p class=MsoNormal align=center style='text-align:center'><spanstyle='font-family:"Times New Roman"'>%Improvement = 100[VApost &#8211;VApre]/VApre.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>As stated above,this gives the physician two static measures of visual function improvement,how much ‘more’ and how much ‘better’ the patient sees. Measuring improvementsin target acquisition time (i.e., how ‘fast’ the patient can acquire a newtarget) requires eye-movement data; these data have documented that the T&amp;Rprocedure (and, therefore, all four-muscle procedures) allows patients to see‘more,’ ‘better,’ and ‘faster” </span><!--[if supportFields]><spanstyle='font-family:"Times New Roman"'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE <span style='mso-element:field-begin'></span><span style="mso-spacerun: yes">&nbsp;</span>ADDINEN.CITE.DATA <![if gte mso 9]><xml> <w:data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w:data></xml><![endif]><span style='mso-element:field-end'></span><spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-family:"Times New Roman"'>(9-12)<!--[if gte mso 9]><xml> <w:data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w:data></xml><![endif]--></span><!--[if supportFields]><span style='font-family:"Times New Roman"'><spanstyle='mso-element:field-end'></span></span><![endif]--><span style='font-family:"Times New Roman"'>.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>The reasonvisual function improvement is best expressed in terms of percentages ratherthan either lines (acuity) or degrees (gaze-angle range) is that percentagesmore accurately reflect the changes in visual function. It should be noted thata 100% improvement in a patient’s visual acuity from 20/400 or 20/200 will makea more dramatic improvement in a patient’s life than a 100% improvement from20/40.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>Measuring visualacuity at various gaze angles in addition to primary position provides theclinical data necessary to determine the improvements in visual functionfollowing therapy. However, only eye-movement recordings can eliminate themisdiagnoses that occur in patients with strabismus and nystagmus.<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>There is oneother topic that is relevant to this report, the <i>primary outcome measure</i></span><spanstyle='font-family:"Times New Roman"'> of studies of INS therapies. As shouldbe evident from the above considerations, the commonly used clinical measure ofpeak visual acuity (usually with head, and therefore, gaze angle uncontrolled)is neither an adequate nor a scientifically valid measure of EOM surgery ornon-surgical therapies of INS. First, because some INS patients will havewaveforms with excellent foveation quality (i.e., high NAFX) at their preferredgaze angle, no therapy will improve that measure despite improvements in othermeasures of visual function. Thus, such studies will be flawed by falsenegative results. Second, because increasing the breadth of the NAFX vs. GazeAngle curve, thereby increasing the range of gaze angles with the highestvisual acuity, results in a more useful increase in visual function than simplyincreasing peak acuity by a line or two, using peak acuity as the primaryoutcome measure will miss this more important measure. Third, just as a motormeasure (ocular alignment) is the primary outcome measure of strabismus surgery(a motor therapy), the primary outcome measure of nystagmus surgery (a motortherapy) should also be a motor measure (i.e., waveform foveation quality asmeasured by the NAFX). Fourth, both ocular alignment (for strabismus surgery)and the NAFX (for nystagmus surgery) are <i>direct</i></span><spanstyle='font-family:"Times New Roman"'> <i>measures</i></span><spanstyle='font-family:"Times New Roman"'> of the therapy whereas binocular acuity(for strabismus surgery) or measured visual acuity (for nystagmus surgery) aretertiary measures subject to many intervening, idiosyncratic, confoundingfactors. <o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='line-height:150%;tab-stops:.5in'><spanstyle='font-family:"Times New Roman"'><b>REFERENCES<o:p></o:p></b></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><!--[if supportFields]><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'><span style='mso-element:field-begin'></span><span style="mso-spacerun: yes">&nbsp;</span>ADDINEN.REFLIST <span style='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>1.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>CEMAS_Working_Group.<i>A National Eye Institute Sponsored Workshop and Publication on TheClassification of Eye Movement Abnormalities and Strabismus (CEMAS). In TheNational Eye Institute Publications (<a href="http://www.nei.nih.gov)">www.nei.nih.gov)</a></i></span><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>. 2001, NationalInstitutes of Health, National Eye Institute: Bethesda, MD.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>2.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF. Fixation characteristics in hereditary congenital nystagmus<i>.</i></span><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'> <i>Am J Optom Arch AmAcad Optom</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'>1973; 50:85-90.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>3.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF. Improving Visual Acuity in Congenital Nystagmus. In: Smith JL, Glaser JS,eds. <i>Neuro-Ophthalmology Symposium of the University of Miami and the BascomPalmer Eye Institute, Vol. VII</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'>. St. Louis: CV Mosby Company, 1973; 98-106.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>4.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF, Flynn JT, Daroff RB. Hereditary congenital nystagmus: An intrafamilialstudy<i>.</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'><i>Arch Ophthalmol</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'>1974; 92:366-74.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>5.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF, Gauthier G, Liberman G, Stark L. Eye movement recordings as a diagnostictool in a case of congenital nystagmus<i>.</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'> <i>Am J Optom Arch Am Acad Optom</i></span><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'> 1972; 49:3-13.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>6.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>SmithJL, Dell'Osso LF. Congenital nystagmus therapy. Cassette Tapes of ClinicalNeuro-Ophthalmology, ed. Smith JL1974; Tape # 23. NOVEL: The Collection of J.Lawton Smith, M.D., North American Neuro-Ophthalmollgy Society.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>7.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>YangD, Hertle RW, Hill VM, Stevens DJ. Gaze-dependent and time-restricted visualacuity measures in patients with Infantile Nystagmus Syndrome (INS)<i>.</i></span><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'> <i>Am J Ophthalmol</i></span><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'> 2005; 139(4):716-8.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>8.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF, Flynn JT. Congenital nystagmus surgery: a quantitative evaluation of theeffects<i>.</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'><i>Arch Ophthalmol</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'>1979; 97:462-9.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>9.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZ, Dell'Osso LF, Jacobs JB, Burnstine RA, Tomsak RL. Effects of tenotomy onpatients with infantile nystagmus syndrome: foveation improvement over abroadened visual field<i>.</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'> <i>JAAPOS</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'> 2006; 10:552-60.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>10.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZI, Dell'Osso LF. A review of the tenotomy nystagmus surgery: origin,mechanism, and general efficacy<i>.</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'> <i>Neuro-Ophthalmol</i></span><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'> 2007; 31:157-65.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>11.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZI, Dell'Osso LF, Tomsak RL, Jacobs JB. Combining recessions (nystagmus andstrabismus) with tenotomy improved visual function and decreased oscillopsiaand diplopia in acquired downbeat nystagmus and in horizontal infantilenystagmus syndrome<i>.</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'> <i>J AAPOS</i></span><span style='font-size:10.0pt;font-family:"Times New Roman"'> 2007; 11:135-41.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'>12.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZI, Dell'Osso LF. Tenotomy procedure alleviates the &quot;slow to see&quot;phenomenon in infantile nystagmus syndrome: model prediction and patient data<i>.</i></span><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'> <i>Vision Res</i></span><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'> 2008; 48:1409-19.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><!--[if supportFields]><spanstyle='font-size:10.0pt;font-family:"Times New Roman"'><span style='mso-element:field-end'></span></span><![endif]--><span style='font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><h2><span style='font-family:"Times New Roman"'><b>Citation<o:p></o:p></b></span></h2><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Times New Roman"'>Although theinformation contained in this paper and its downloading are free, pleaseacknowledge its source by citing the paper as follows:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Times New Roman";color:black'>Dell’Osso, L.F.: </span><span style='font-size:10.0pt;font-family:"Times New Roman"'>How Someone with INS ‘Sees’ the World and How to ClinicallyAssess Therapeutic Improvements in Visual Function<span style='color:black'>.OMLAB Report #030509, 1-6, 2009. </span></span><span style='font-size:10.0pt'><ahref="http://www.omlab.org/Teaching/teaching.html"><span style='font-family:"Times New Roman"'>http://www.omlab.org/Teaching/teaching.html</span></a></span><spanstyle='font-family:"Times New Roman"'><o:p></o:p></span></p></div></body></html>